![(6aS)-2-methoxy-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinolin-1-ol](https://static.cymitquimica.com/cas-image/436658-6as-2-methoxy-6-methyl-566a-7-tetrahydro-4h-dibenzo-de-g-quinolin-1-ol.png)
CAS: 54383-28-7 - (6aS)-2-methoxy-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinolin-1-ol
Formula:C18H19NO2
InChI:InChI=1/C18H19NO2/c1-19-8-7-12-10-15(21-2)18(20)17-13-6-4-3-5-11(13)9-14(19)16(12)17/h3-6,10,14,20H,7-9H2,1-2H3/t14-/m0/s1
- Synonyms:
- 4H-Dibenzo(de,g)quinolin-1-ol, 5,6,6a,7-tetrahydro-2-methoxy-6-methyl-, (S)-
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Lirinidine REF: 7W-GY7252CAS: 54383-28-7 | - - - | To inquire | Fri 24 Jan 25 |
 | Lirinidine REF: BP-BP4393CAS: 54383-28-7 | 95%~99% | 196.00 €~529.00 € | Tue 28 Jan 25 |
 | Lirinidine REF: TM-TN1873CAS: 54383-28-7 | 98.76% | 78.00 €~581.00 € | Thu 30 Jan 25 |
 | Lirinidine REF: 3D-ECA38328CAS: 54383-28-7 | Min. 95% | 352.00 €~2,155.00 € | Thu 06 Mar 25 |
Ref: 7W-GY7252
| Undefined size | To inquire |
Estimated delivery in United States, on Friday 24 Jan 2025
Ref: BP-BP4393
| 5mg | 196.00 € | ||
| 10mg | 326.00 € | ||
| 20mg | 529.00 € |
Estimated delivery in United States, on Tuesday 28 Jan 2025
Lirinidine
CAS:54383-28-7
(+)-Lirinidine shows antioxidative properties, inhibits melanoma and melanogenesis, and reduces collagen-related platelet aggregation.
Formula:
C18H19NO2
Purity:
98.76%
Color and Shape:
Solid
Molecular weight:
281.35
Ref: TM-TN1873
| 1mg | 78.00 € | ||
| 5mg | 162.00 € | ||
| 10mg | 233.00 € | ||
| 25mg | 390.00 € | ||
| 50mg | 581.00 € | ||
| 1mL*10mM (DMSO) | 180.00 € |
Estimated delivery in United States, on Thursday 30 Jan 2025
Lirinidine
CAS:54383-28-7
Lirinidine is a drug that is used to control symptoms of pain, depression, and anxiety. …
Formula:
C18H19NO2
Purity:
Min. 95%
Molecular weight:
281.3 g/mol
Ref: 3D-ECA38328
| 5mg | 352.00 € | ||
| 10mg | 501.00 € | ||
| 25mg | 895.00 € | ||
| 50mg | 1,347.00 € | ||
| 100mg | 2,155.00 € |
Estimated delivery in United States, on Thursday 6 Mar 2025
